Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
7.59% $12.49
America/New_York / 3 mai 2024 @ 09:37
FUNDAMENTALS | |
---|---|
MarketCap: | 5 548.53 mill |
EPS: | 0.590 |
P/E: | 21.17 |
Earnings Date: | Mar 05, 2024 |
SharesOutstanding: | 444.24 mill |
Avg Daily Volume: | 0.0002 mill |
RATING 2024-05-03 |
---|
B+ |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Neutral | |
Return On Asset: | Buy | |
DE: | Buy | |
P/E: | Neutral | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | n/a | n/a | n/a | |||
Gr.Profit | n/a | n/a | n/a | |||
Ebit | n/a | n/a | n/a | |||
Asset | n/a | |||||
Debt | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.73x |
Company: PE 21.17 | sector: PE 29.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.67x |
Company: PE 21.17 | industry: PE 31.46 |
DISCOUNTED CASH FLOW VALUE |
---|
$0.247 (-98.02%) $-12.24 |
Date: 2024-05-05 |
Expected Trading Range (DAY) |
---|
$ 12.36 - 12.63 ( +/- 1.08%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 |
Volume Signals | |
---|---|
Price | $12.49 (7.59% ) |
Volume | 0.0001 mill |
Avg. Vol. | 0.0002 mill |
% of Avg. Vol | 56.48 % |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.